Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from 60 Prospectively Treated Patients

Journal of Palliative Medicine, Ahead of Print.

Source: Journal of Palliative Medicine - May 24, 2018 Category: Palliative Care Authors: Jason D. Doles Kelly A. Hogan Jennifer O'Connor Andrea E. Wahner Hendrickson Olivia Huston Aminah Jatoi Source Type: research